Please assess the completion status of the following clinical trial:

Trial Title: Study of A3309 in Patients With Dyslipidemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients meet protocol specified criteria for dyslipidemia and has successfully completed study requirements with no clinically relevant findings~Exclusion Criteria:~* Medical history or medical condition that would not make the patient a good candidate for the study or would limit the patient´s capability to complete the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- A3309 low dose (Type: EXPERIMENTAL): None
- A3309 high dose (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).